China Shenghuo Pharmaceutical Holdings,Inc.
Founded in 1995, China Shenghuo Pharmaceutical Holdings, Inc. (?the
Company,??China Shenghuo?) is a leading specialty pharmaceutical
company that focuses on the research, development, production and
marketing of Sanchi-based medicinal products. Through its
subsidiary, Kunming Shenghuo Pharmaceutical (Group) Co., Ltd
(?Kunming Shenghuo?), it owns thirty-one SFDA (State Food and Drug
Association)-approved medicines, including the flagship product
Xuesaitong Soft Capsules, which has already been listed in the
Insurance Catalogue. At present, Shenghuo incorporates a sales
network of agencies and representatives throughout China, which
markets Sanchi-based traditional Chinese medicine into 1,650
hospitals and 1,500 drug stores as prescription and OTC drugs
primarily for the treatment of cardiovascular, cerebrovascular and
peptic ulcer disease. The Company also exports medicinal products
to Asian countries such as Indonesia, Thailand and Kyrgyzstan.
The company has received much acclaim in the last 10 years,
including the support of the State Science and Technology Ministry,
State Commerce Ministry, State Traditional Chinese Medicine
Administration and the government of Yunnan province and Kunming,
and we are among the largest producers of soft capsules in Asia.
Our Xue Sai Tong Soft Capsules have earned honors within Yunnan
Province, and the product?s market share is the largest among the